CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CCD) FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS: INITIAL RESULTS OF A MULTICENTER, OPEN LABEL PHASE II STUDY

被引：0
|
作者：
Bringhen, S. [1 ]
Federica, C. [1 ]
Petrucci, M. [2 ]
Gay, F. [1 ]
Federico, V. [2 ]
Conticello, C. [2 ]
Pantani, L. [2 ]
Montefusco, V. [2 ]
Benevolo, G. [2 ]
Aschero, S. [1 ]
Offidani, M. [2 ]
Villani, O. [2 ]
Siniscalchi, A. [2 ]
Rossi, D. [2 ]
Magarotto, V. [1 ]
Sonneveld, P. [3 ]
Boccadoro, M. [1 ]
Palumbo, A. [1 ]
机构：
[1] Univ Torino, Div Hematol, Myeloma Unit, Turin, Italy
[2] GIMEMA, Italian Multiple Myeloma Network, Rome, Italy
[3] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S578
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [1] Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients
    Palumbo, Antonio
    Bringhen, Sara
    Villani, Oreste
    Siniscalchi, Agostina
    Russo, Eleonora
    Uccello, Giuseppina
    Cerrato, Chiara
    Gilestro, Milena
    Rossi, Davide
    Boccadoro, Mario
    BLOOD, 2012, 120 (21)
  • [2] A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma
    Bringhen, Sara
    Cerrato, Chiara
    Petrucci, Maria Teresa
    Genuardi, Mariella
    Gentilini, Fabiana
    Conticello, Concetta
    Oliva, Stefania
    Pantani, Lucia
    Offidani, Massimo
    Palladino, Carmela
    Benevolo, Giulia
    Montefusco, Vittorio
    Astolfi, Monica
    Villani, Oreste
    Siniscalchi, Agostina
    Rocci, Alberto
    De Paoli, Lorenzo
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
  • [3] Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study
    Bringhen, Sara
    Petrucci, Maria Teresa
    Larocca, Alessandra
    Conticello, Concetta
    Rossi, Davide
    Magarotto, Valeria
    Musto, Pellegrino
    Boccadifuoco, Luana
    Offidani, Massimo
    Omede, Paola
    Gentilini, Fabiana
    Ciccone, Giovannino
    Benevolo, Giulia
    Genuardi, Mariella
    Montefusco, Vittorio
    Oliva, Stefania
    Caravita, Tommaso
    Tacchetti, Paola
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    BLOOD, 2014, 124 (01) : 63 - 69
  • [4] CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (KCYD) IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS: INITIAL RESULTS OF A PHASE 1 STUDY
    Bringhen, S.
    Musto, P.
    Gay, F.
    Giuliani, N.
    Liberati, A. M.
    Pautasso, C.
    Ponticelli, E.
    De Paoli, L.
    Zambello, R.
    Ciccone, G.
    Carella, A. M.
    Boccadoro, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2016, 101 : 520 - 520
  • [5] A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
    Boccia, Ralph V.
    Bessudo, Alberto
    Agajanian, Richy
    Conkling, Paul
    Harb, Wael
    Yang, Hui
    Pinchasik, Dawn
    Kimball, Amy S.
    Berenson, James R.
    BLOOD, 2016, 128 (22)
  • [6] A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
    Boccia, Ralph V.
    Bessudo, Alberto
    Agajanian, Richy
    Conkling, Paul
    Harb, Wael
    Yang, Hui
    Pinchasik, Dawn
    Kimball, Amy S.
    Berenson, James R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (07): : 433 - 437
  • [7] A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
    Boccia, Ralph
    Bessudo, Alberto
    Agajanian, Richy
    Conkling, Paul
    Harb, Wael
    Yang, Hui
    Pinchasik, Dawn
    Kimball, Amy
    Berenson, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E14 - E14
  • [8] An Open-Label Phase I/II Study of Carfilzomib, Bendamustine and Dexamethasone (CBD) in Newly Diagnosed Multiple Myeloma Patients
    Leng, Siyang
    Raza, Shahzad
    Assal, Amer
    Baliko, Gregory
    Gould, Julia
    Shields, Rachel K.
    Mapara, Markus Y.
    Lentzsch, Suzanne
    BLOOD, 2017, 130
  • [9] A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) Patients
    Bringhen, Sara
    Magarotto, Valeria
    Liberati, Anna Marina
    Belotti, Angelo
    Larocca, Alessandra
    Gilestro, Milena
    Bonello, Francesca
    Gaidano, Gianluca
    Bertazzoni, Paola
    Stocchi, Raffaella
    Ribolla, Rossella
    Di Sano, Chiara
    Patriarca, Francesca
    Passera, Roberto
    De Paoli, Lorenzo
    Oliva, Stefania
    Cafro, Anna Maria
    Sonneveld, Pieter
    Palumbo, Antonio
    Boccadoro, Mario
    BLOOD, 2016, 128 (22)
  • [10] Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCyd) in Elderly Newly Diagnosed Multiple Myeloma Patients: Results of a Phase 2 Study
    Bringhen, Sara
    Rossi, Davide
    Larocca, Alessandra
    Corradini, Paolo
    Galieni, Piero
    Malfitano, Alessandra
    Aschero, Simona
    Offidani, Massimo
    Liberati, Anna Marina
    Genuardi, Mariella
    Gaidano, Gianluca
    Palladino, Carmela
    Gentilini, Fabiana
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    BLOOD, 2015, 126 (23)
12345